Early-stage funding as the silent driver of success in cutting-edge science
From the stars to precision medicine Biomarkers to get ahead of Alzheimer’s Artificial intelligence against superbugs Scientific outreach often focuses on the final milestone, that tangible result that grabs the headlines: a new drug, a revolutionary …